AG
RPTP

Aperio Group’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Aperio Group’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-12,537
Closed -$112K – 2183
2016
Q3 		$112K Buy
12,537
+1,315
+12% +$9.35K ﹤0.01% 2016
2016
Q2 		$60K Buy
+11,222
New +$57.5K ﹤0.01% 1983

Aperio Group's RPTP Position: Q4 2016 in Review

Aperio Group sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 12,537 shares — an estimated $112K sold.

Aperio Group first reported a position in RPTP in Q2 2016 and held it in 2 quarters. The position peaked at $112K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Aperio Group reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Aperio Group sold 12,537 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $112K.
  • Aperio Group first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2016 and held it in 2 quarters.
  • Aperio Group's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $112K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Aperio Group's 13F filing for Q4 2016, filed 14 Feb 2017.